Works matching DE "REMDESIVIR"
Results: 523
Simulation-based insights into Remdesivir coating on Ag nanoparticles for optimized COVID-19 drug delivery.
- Published in:
- Journal of the Iranian Chemical Society, 2025, v. 22, n. 2, p. 271, doi. 10.1007/s13738-024-03147-y
- By:
- Publication type:
- Article
Remdesivir significantly reduces SARS‐CoV‐2 viral load on nasopharyngeal swabs in hospitalized patients with COVID‐19: A retrospective case–control study.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 5, p. 2284, doi. 10.1002/jmv.27598
- By:
- Publication type:
- Article
Prediction of in‐hospital mortality with machine learning for COVID‐19 patients treated with steroid and remdesivir.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 3, p. 958, doi. 10.1002/jmv.27393
- By:
- Publication type:
- Article
Evolution of viral variants in remdesivir-treated and untreated SARS-CoV-2-infected pediatrics patients.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 1, p. 161, doi. 10.1002/jmv.27285
- By:
- Publication type:
- Article
Therapeutic interventions of remdesivir in diabetic and nondiabetic COVID‐19 patients: A prospective observational study conducted on Pakistani population.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 12, p. 6732, doi. 10.1002/jmv.27256
- By:
- Publication type:
- Article
Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019—The pilot study.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 10, p. 5724, doi. 10.1002/jmv.27177
- By:
- Publication type:
- Article
Remdesivir for the treatment of COVID‐19 in pregnancy.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 7, p. 4114, doi. 10.1002/jmv.26986
- By:
- Publication type:
- Article
Early remdesivir treatment in COVID‐19: Why wait another day?
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 7, p. 4078, doi. 10.1002/jmv.26792
- By:
- Publication type:
- Article
The safety of remdesivir for COVID‐19 patients.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 4, p. 1910, doi. 10.1002/jmv.26735
- By:
- Publication type:
- Article
Effect of remdesivir on mortality in patients with COVID‐19: A meta‐analysis of randomized control trials.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 4, p. 1860, doi. 10.1002/jmv.26638
- By:
- Publication type:
- Article
Effectiveness of remdesivir for the treatment of hospitalized COVID‐19 persons: A network meta‐analysis.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 2, p. 1171, doi. 10.1002/jmv.26443
- By:
- Publication type:
- Article
Remdesivir and tocilizumab: Mix or match.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 1, p. 56, doi. 10.1002/jmv.26117
- By:
- Publication type:
- Article
Synthetic strategies for pyrrolo[2,1-f][1,2,4]triazine: the parent moiety of antiviral drug remdesivir.
- Published in:
- Chemistry of Heterocyclic Compounds, 2020, v. 56, n. 12, p. 1517, doi. 10.1007/s10593-020-02844-9
- By:
- Publication type:
- Article
Ototoxic and Vestibulotoxic Effects of Chloroquine/Hydroxychloroquine and Remdesivir in the Treatment of COVID-19: Update Review.
- Published in:
- Journal of Modern Rehabilitation, 2023, v. 17, n. 3, p. 219, doi. 10.18502/jmr.v17i3.13062
- By:
- Publication type:
- Article
Remdesivir experience in patients diagnosed with COVID-19 in a tertiary hospital.
- Published in:
- Pamukkale Medical Journal, 2023, v. 16, n. 1, p. 1, doi. 10.31362/patd.1102822
- By:
- Publication type:
- Article
A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection.
- Published in:
- Experimental Biomedical Research, 2020, v. 3, n. 4, p. 293, doi. 10.30714/j-ebr.2020463629
- By:
- Publication type:
- Article
Impact of Extracorporeal Membrane Oxygenation Circuitry on Remdesivir.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2024, v. 29, n. 3, p. 248, doi. 10.5863/1551-6776-29.3.248
- By:
- Publication type:
- Article
Remdesivir treatment for patients with moderate to severe COVID-19.
- Published in:
- Turkish Journal of Medical Sciences, 2022, v. 52, n. 4, p. 880, doi. 10.55730/1300-0144.5387
- By:
- Publication type:
- Article
Simultaneous HPLC determination of remdesivir and dexamethasone in the presence of metformin, sitagliptin, and glimepiride in a synthetic mixture and spiked human plasma.
- Published in:
- Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e120463
- By:
- Publication type:
- Article
The kinetics of SARS-CoV-2 viremia in COVID-19 patients receiving remdesivir.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 8, p. 951, doi. 10.1007/s10096-023-04627-4
- By:
- Publication type:
- Article
Research towards treating COVID-19.
- Published in:
- British Journal of Community Nursing, 2020, v. 25, n. 4, p. 204, doi. 10.12968/bjcn.2020.25.4.204
- By:
- Publication type:
- Article
Clinical course and disease outcome in patients with severe COVID-19 receiving remdesivir.
- Published in:
- Journal of Shahrekord University of Medical Sciences, 2022, v. 24, n. 1, p. 7, doi. 10.34172/jsums.2022.02
- By:
- Publication type:
- Article
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-56195-y
- By:
- Publication type:
- Article
Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42704-y
- By:
- Publication type:
- Article
Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42704-y
- By:
- Publication type:
- Article
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 7, p. 1589, doi. 10.1007/s40121-024-00994-3
- By:
- Publication type:
- Article
Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 7, p. 1703, doi. 10.1007/s40121-024-00991-6
- By:
- Publication type:
- Article
K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 4, p. 715, doi. 10.1007/s40121-024-00938-x
- By:
- Publication type:
- Article
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 10, p. 2471, doi. 10.1007/s40121-023-00874-2
- By:
- Publication type:
- Article
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 6, p. 1655, doi. 10.1007/s40121-023-00816-y
- By:
- Publication type:
- Article
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 4, p. 1189, doi. 10.1007/s40121-023-00789-y
- By:
- Publication type:
- Article
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 1, p. 257, doi. 10.1007/s40121-022-00729-2
- By:
- Publication type:
- Article
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 3, p. 525, doi. 10.1007/s40121-020-00318-1
- By:
- Publication type:
- Article
Detection of potential safety signals related to the use of remdesivir and tocilizumab in the COVID era during pregnancy, resorting to open data from the FDA adverse event reporting system (FAERS).
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1349543
- By:
- Publication type:
- Article
A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1218650
- By:
- Publication type:
- Article
Evaluation of safety and effectiveness of remdesivir in treating COVID-19 patients after emergency use authorization study.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1205238
- By:
- Publication type:
- Article
Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2.
- Published in:
- Frontiers in Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fmicb.2020.592908
- By:
- Publication type:
- Article
Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study.
- Published in:
- Clinical Interventions in Aging, 2021, v. 16, p. 1037, doi. 10.2147/CIA.S313028
- By:
- Publication type:
- Article
Safety of Remdesivir Use In Patients With Severely Impaired Renal Function.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 337
- By:
- Publication type:
- Article
Clinical safety of remdesivir therapy in COVID-19 patients with renal insufficiency.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 321
- By:
- Publication type:
- Article
Safety of remdesivir vs placebo in non-hospitalized patients with COVID-19.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S360
- By:
- Publication type:
- Article
Remdesivir in an outpatient setting improves biomarkers for progression of COVID-19.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S358
- By:
- Publication type:
- Article
A Meta-Analysis of Association between Remdesivir and Mortality among Critically-Ill COVID-19 Patients.
- Published in:
- Infection & Chemotherapy, 2021, v. 53, n. 3, p. 512, doi. 10.3947/ic.2021.0060
- By:
- Publication type:
- Article
Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series.
- Published in:
- Infection & Chemotherapy, 2020, v. 52, n. 3, p. 369, doi. 10.3947/ic.2020.52.3.369
- By:
- Publication type:
- Article
Association Between Concomitant Hydroxychloroquine Use and Safety and Efficacy of Remdesivir in Severe COVID-19 Patients.
- Published in:
- Infection & Chemotherapy, 2020, v. 52, p. S380
- By:
- Publication type:
- Article
The effect of remdesivir on selective biomarkers and its value in predicting the clinical outcome in patients with COVID-19.
- Published in:
- Asian Journal of Medical Sciences, 2021, v. 12, n. 12, p. 3, doi. 10.3126/ajms.v12i12.39164
- By:
- Publication type:
- Article
Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 6, p. 947, doi. 10.3390/v16060947
- By:
- Publication type:
- Article
Availability of Research Articles for the Public During Pandemic -- A Case Study.
- Published in:
- Liber Quarterly: The Journal of European Research Libraries, 2020, v. 30, n. 1, p. 1, doi. 10.18352/lq.10340
- By:
- Publication type:
- Article
Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0255093
- By:
- Publication type:
- Article